CDVZX
Price
$17.45
Change
+$0.13 (+0.75%)
Updated
Jul 3 closing price
Net Assets
2.49B
VIVAX
Price
$70.13
Change
+$0.40 (+0.57%)
Updated
Jul 3 closing price
Net Assets
188.77B
Interact to see
Advertisement

CDVZX vs VIVAX

Header iconCDVZX vs VIVAX Comparison
Open Charts CDVZX vs VIVAXBanner chart's image
Columbia Large Cap Value Inst
Price$17.45
Change+$0.13 (+0.75%)
VolumeN/A
Net Assets2.49B
Vanguard Value Index I
Price$70.13
Change+$0.40 (+0.57%)
VolumeN/A
Net Assets188.77B
CDVZX vs VIVAX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
CDVZX vs. VIVAX commentary
Jul 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CDVZX is a Buy and VIVAX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VIVAX has more cash in the bank: 189B vs. CDVZX (2.49B). VIVAX pays higher dividends than CDVZX: VIVAX (2.06) vs CDVZX (1.31). CDVZX was incepted earlier than VIVAX: CDVZX (15 years) vs VIVAX (33 years). CDVZX (0.74) is less costly to investors than VIVAX (0.17). CDVZX is a more actively managed with annual turnover of: 17.00 vs. VIVAX (9.00). CDVZX has a lower initial minimum investment than VIVAX: CDVZX (2000) vs VIVAX (3000). VIVAX annual gain was more profitable for investors over the last year : 12.04 vs. CDVZX (6.86). VIVAX return over 5 years is better than : 80.14 vs. CDVZX (57.13).
CDVZXVIVAXCDVZX / VIVAX
Total Expense Ratio0.720.17424%
Annual Report Gross Expense Ratio0.740.17435%
Fund Existence15 years33 years-
Gain YTD8.5036.209137%
Front LoadN/AN/A-
Min. Initial Investment2000300067%
Min. Initial Investment IRAN/AN/A-
Net Assets2.49B189B1%
Annual Yield % from dividends1.312.0663%
Returns for 1 year6.8612.0457%
Returns for 3 years20.7535.1659%
Returns for 5 years57.1380.1471%
Returns for 10 years39.23115.7434%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
SOL1.910.03
+1.60%
Emeren Group Ltd
CE60.880.26
+0.43%
Celanese Corp
BNL16.340.03
+0.18%
Broadstone Net Lease
BCLI1.16-0.01
-0.85%
Brainstorm Cell Therapeutics
ECX2.16-0.04
-1.82%
ECARX Holdings